Fungi

Farmmi's CEO Elected Vice President of Influential Association's Council of Shiitake Branch

Retrieved on: 
Tuesday, November 10, 2020

LISHUI, China, Nov. 10, 2020 /PRNewswire/ -- Farmmi, Inc. ("Farmmi" or the "Company")(NASDAQ: FAMI), an agriculture products supplier in China, today announced its Chairwoman and CEO, Ms. Yefang Zhang, was elected, Vice President of the third council of Shiitake Branch of the China Edible Fungi Association ("the Association").The appointment was formally made at the November 4, 2020 China Edible Fungi Industry Development Conference and Xixia Mushroom Fair.

Key Points: 
  • LISHUI, China, Nov. 10, 2020 /PRNewswire/ -- Farmmi, Inc. ("Farmmi" or the "Company")(NASDAQ: FAMI), an agriculture products supplier in China, today announced its Chairwoman and CEO, Ms. Yefang Zhang, was elected, Vice President of the third council of Shiitake Branch of the China Edible Fungi Association ("the Association").The appointment was formally made at the November 4, 2020 China Edible Fungi Industry Development Conference and Xixia Mushroom Fair.
  • This announcement contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
  • All statements other than statements of historical fact in this announcement are forward-looking statements, including the potential impact of COVID-19 on our business within and outside of China.
  • The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law.

Global Chaga Mushroom-Based Products Market 2020-2024

Retrieved on: 
Friday, November 6, 2020
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20201105005782/en/
    Technavio has announced its latest market research report titled Global Chaga Mushroom-Based Products Market 2020-2024 (Graphic: Business Wire)
    Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19.
  • Download Free Sample Report on COVID-19 Recovery Analysis
    The report on the Chaga mushroom-based products market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
  • The Chaga mushroom-based products market analysis includes application segment and geography landscape.
  • This study identifies the launch of new Chaga mushroom-based products as one of the prime reasons driving the Chaga mushroom-based products market growth during the next few years.

Global $4.6 Billion Cryptococcosis Treatment Market to 2025: Impact of Covid-19, Porters Five Forces Analysis, Ansoff Matrix Analysis

Retrieved on: 
Monday, November 2, 2020

DUBLIN, Nov. 2, 2020 /PRNewswire/ -- The "Global Cryptococcosis Treatment Market 2020-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Nov. 2, 2020 /PRNewswire/ -- The "Global Cryptococcosis Treatment Market 2020-2025" report has been added to ResearchAndMarkets.com's offering.
  • Alternatively, lack of efficient diagnostic tools and trials to prevent this infection are digressing the growth of this market.
  • Cryptococcosis or cryptococcal disease is basically a fungal disease, which can prove to be fatal in severe cases.
  • The report includes in-depth market analysis using Porter's 5 force model and the Ansoff Matrix.

Matinas BioPharma Announces Unanimous DSMB Approval to Progress into Second Cohort of Patients in the EnACT Study of MAT2203 (Oral Amphotericin B) for the Treatment of Cryptococcal Meningitis

Retrieved on: 
Monday, October 19, 2020

Cohort progression in the EnACT study is an important milestone for the development of MAT2203, commented Theresa Matkovits, Ph.D., Chief Development Officer of Matinas BioPharma.

Key Points: 
  • Cohort progression in the EnACT study is an important milestone for the development of MAT2203, commented Theresa Matkovits, Ph.D., Chief Development Officer of Matinas BioPharma.
  • The unanimous DSMB recommendation is very encouraging and supports our views of the overall safety and efficacy profile of MAT2203.
  • In total, the trial includes four cohorts of patients, with each cohort increasing the treatment duration of MAT2203 vs. IV amphotericin B.
  • MAT2203 is currently in a Phase 2 open-label, sequential cohort study (EnACT) in HIV-infected patients with cryptococcal meningitis.

Fungi Perfecti® - Makers of Host Defense® Mushrooms™ Supplements - Introduces 4 New Mushroom Mycelium Superfood Products

Retrieved on: 
Thursday, October 8, 2020

OLYMPIA, Wash., Oct. 8, 2020 /PRNewswire/ --Fungi Perfecti, LLC (maker of Host Defense Mushrooms) launched 3 new MycoBotanicals Powders Microbiome, Greens, and Complete Calm, and Elderberry Plus, a mushroom mycelium-based elderberry syrup.

Key Points: 
  • OLYMPIA, Wash., Oct. 8, 2020 /PRNewswire/ --Fungi Perfecti, LLC (maker of Host Defense Mushrooms) launched 3 new MycoBotanicals Powders Microbiome, Greens, and Complete Calm, and Elderberry Plus, a mushroom mycelium-based elderberry syrup.
  • Each of the new products contains a hand-crafted, synergistic blend of superfood mushroom mycelium and herbs.All 4 products are available at fungi.com and hostdefense.com , and can also be found at health food stores nationwide.
  • The MycoBotanicalsPowder line now includes 3 new hand-crafted blends of mushrooms and herbs:
    Microbiome This Pre & Probiotic formula is specially formulated for digestive health.
  • Elderberry Plus Syrup This delicious-tasting blend of superfood mushroom mycelium and Elderberry is ideal for people seeking daily immune support, respiratory health, and antioxidant activity.

InvestorBrandNetwork (IBN) Coverage Initiated for Rritual Mushrooms Inc.

Retrieved on: 
Wednesday, October 7, 2020

Rritual Mushrooms is a private company, founded in 2019, whose declared purpose is to help people meet the demands of modern life with style and ease by incorporating functional mushrooms, adaptogens and superfoods into their diets.

Key Points: 
  • Rritual Mushrooms is a private company, founded in 2019, whose declared purpose is to help people meet the demands of modern life with style and ease by incorporating functional mushrooms, adaptogens and superfoods into their diets.
  • The company manufactures premium plant-based products such as small-batch elixir powders, with each product featuring mindfully selected medicinal mushrooms and adaptogenic herbs.
  • IBN is uniquely positioned to provide Rritual the solutions needed to reach a wide audience of investors, consumers, journalists and the general public.
  • To learn more about Rritual Mushrooms, visit the company's corporate newsroom profile at www.IBN.fm/Rritual
    Launched in 2019, Rritual makes premium plant-based elixir products in small batches featuring mindfully selected medicinal mushrooms and adaptogenic herbs.

FDA In Brief: FDA Advises Restaurants to Not Sell or Serve Recalled Wood Ear Mushrooms, Investigation Continues

Retrieved on: 
Thursday, September 24, 2020

"Restaurants should not sell or serve recalled wood ear mushrooms distributed by Wismettac Asian Foods, Inc., labeled as Shirakiku brand Black Fungus (Kikurage).

Key Points: 
  • "Restaurants should not sell or serve recalled wood ear mushrooms distributed by Wismettac Asian Foods, Inc., labeled as Shirakiku brand Black Fungus (Kikurage).
  • "Wood ear mushrooms imported by Wismettac Asian Foods, Inc. were only sold to restaurants and were not available directly to consumers.
  • The FDA, along with CDC and state and local partners, is investigating a multistate outbreak of Salmonella Stanley infections likely linked to wood ear mushrooms from one company.
  • Wismettac Asian Foods, Inc. acted quickly upon being notified of the positive test result and recalled all wood ear mushrooms within shelf life on Sept. 23, 2020.

Global $599 Million Organic Yeast (Extracts, Derivatives, Inactive Dry, Yeast) Market Forecast to 2025 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, September 23, 2020

The "Global Organic Yeast Market by Type (Yeast Extracts, Yeast Derivatives, Inactive Dry Yeast, Nutritional Yeast), Application (Food, Beverage, Nutrition, Feed), Species (Saccharomyces, Torulaspora, Candida, Kluyveromyces) and Region - Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Organic Yeast Market by Type (Yeast Extracts, Yeast Derivatives, Inactive Dry Yeast, Nutritional Yeast), Application (Food, Beverage, Nutrition, Feed), Species (Saccharomyces, Torulaspora, Candida, Kluyveromyces) and Region - Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
  • The global organic yeast market is estimated to be valued at USD 364 million in 2020.
  • It is projected to reach a value of USD 599 million by 2025, growing at a CAGR of 10.5% during the forecast period.
  • "The increase in the demand for nutritional foods is one of the major driving factors for the organic yeast market.

Global Cryptococcosis Treatment Market Report 2020: Market is Expected to Grow from USD 5,959.88 Million in 2019 to USD 7,923.56 Million by the End of 2025

Retrieved on: 
Tuesday, September 22, 2020

Based on Treatment, the Cryptococcosis Treatment Market studied across Amphotericin B, Fluconazole, and Flucytosine.

Key Points: 
  • Based on Treatment, the Cryptococcosis Treatment Market studied across Amphotericin B, Fluconazole, and Flucytosine.
  • The Fluconazole commanded the largest size in the Cryptococcosis Treatment Market in 2019.
  • Based on Distribution, the Cryptococcosis Treatment Market studied across Hospital Pharmacies, Mail Order Pharmacies, and Retail Pharmacies & Drug Stores.
  • The Retail Pharmacies & Drug Stores commanded the largest size in the Cryptococcosis Treatment Market in 2019.

Paul Stamets is a Fellow in the Explorers Club!

Retrieved on: 
Wednesday, September 16, 2020

Paul's extensive work in the field of mycology has earned him an official induction into the Explorers Club.

Key Points: 
  • Paul's extensive work in the field of mycology has earned him an official induction into the Explorers Club.
  • Paul is now among a group of Explorers who have revolutionized their areas of expertise, including Jane Goodall, Sir Edmund Hillary, and Neil Armstrong.
  • The visionary research and stewardship of Paul Stamets has led to significant breakthroughs revealing the power and potential of mushrooms and mushroom mycelium.
  • Upon learning of Paul's induction into the Explorers Club, film-maker Louie Schwartzberg said:
    It is so deserving for Paul Stamets to be inducted as a fellow into the Explorers Club, in the great tradition of the members who scaled icy mountain peaks and penetrated tangled jungles.